KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Jazz Pharmaceuticals (JAZZ) Return on Invested Capital (2016 - 2025)

Jazz Pharmaceuticals has reported Return on Invested Capital over the past 14 years, most recently at 0.0% for Q4 2025.

  • Quarterly Return on Invested Capital fell 9.0% to 0.0% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.0% through Dec 2025, down 9.0% year-over-year, with the annual reading at 0.02% for FY2025, 11.0% down from the prior year.
  • Return on Invested Capital was 0.0% for Q4 2025 at Jazz Pharmaceuticals, down from 0.0% in the prior quarter.
  • Over five years, Return on Invested Capital peaked at 0.1% in Q1 2021 and troughed at 0.06% in Q3 2021.
  • The 5-year median for Return on Invested Capital is 0.01% (2021), against an average of 0.03%.
  • Biggest five-year swings in Return on Invested Capital: dropped -11bps in 2021 and later increased 9bps in 2023.
  • Tracing JAZZ's Return on Invested Capital over 5 years: stood at 0.05% in 2021, then crashed by -109bps to 0.0% in 2022, then skyrocketed by 2097bps to 0.09% in 2023, then fell by -4bps to 0.08% in 2024, then crashed by -104bps to 0.0% in 2025.
  • According to Business Quant data, Return on Invested Capital over the past three periods came in at 0.0%, 0.0%, and 0.0% for Q4 2025, Q3 2025, and Q2 2025 respectively.